European Society of Clinical Microbiology and Infectious Diseases
- World rank, all time
- #18,202 of 42,892
- Rank in Switzerland
- #181 of 429
- Research works
- 123 ▲ 143% vs 2013–17
- Citations
- 3.5k 28.6 per fractional work
- Top-10% rate
- 32.8% record average 16.5%
- Open access
- 71% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.3×. Every wedge is a field page.
- Immunology and Microbiology 11.3×
- Medicine 2.8×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Health Professions 2.0×
- Veterinary 1.5×
- Decision Sciences 1.4×
- Dentistry 1.1×
- Environmental Science 0.7×
- Agricultural and Biological Sciences 0.4×
- Earth and Planetary Sciences 0.4×
- Neuroscience 0.4×
- Social Sciences 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Psychology 0.2×
- Chemistry 0.2×
- Arts and Humanities 0.2×
- Nursing 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Mathematics 0.1×
- Business, Management and Accounting 0.1×
- Economics, Econometrics and Finance 0.0×
Which keywords describe research at European Society of Clinical Microbiology and Infectious Diseases?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Antibiotic Resistance, Public Health, Healthcare-Associated Infections, Vaccine, Clinical Practice Guidelines and Infectious Diseases.
- Epidemiological Study
- Pneumococcal Conjugate Vaccine
- Legionella
- Genomics
- Amoebae
- SARS-CoV-2
- Genetic Diversity
- Microbial Communities
- Antimicrobial Stewardship
- Global Health
- COVID-19
- Fecal Microbiota Transplantation
- Risk Factors
- Immune Response
- Diagnosis
- Antimicrobial Resistance
- Infectious Diseases
- Vaccine
- Antibiotic Resistance
- Pathogenesis
- Epidemiology
- Public Health
- Healthcare-Associated Infections
- Clinical Practice Guidelines
- Virulence Factors
- Treatment
- Vaccine Development
- Infection
- Antibiotic-Associated Diarrhea
- Clinical Management
- Drug Resistance
- Genomic Analysis
- Bacterial Infections
- Virus
- Respiratory Infections
- Vaccination
- Antifungal Therapy
- Immunity
- Community-Acquired Pneumonia
- Biofilms
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology19▲ 9.3×51 topics
- Pathogenesis6▲ 23×16 topics
- Public Health5▲ 6.8×18 topics
- Antibiotic Resistance5▲ 24×10 topics
- Healthcare-Associated Infections5▲ 75×5 topics
- Vaccine4▲ 20×9 topics
- Clinical Practice Guidelines4▲ 14×3 topics
- Infectious Diseases4▲ 21×7 topics
- Virulence Factors4▲ 48×7 topics
- Antimicrobial Resistance3▲ 33×6 topics
- Treatment3▲ 5.4×13 topics
- Diagnosis3▲ 6.8×12 topics
- Vaccine Development3▲ 24×6 topics
- Immune Response3▲ 9.8×11 topics
- Infection3▲ 23×5 topics
- Risk Factors3▲ 4.5×5 topics
- Antibiotic-Associated Diarrhea2▲ 144×1 topic
- Fecal Microbiota Transplantation2▲ 144×1 topic
- Clinical Management2▲ 23×3 topics
- COVID-192▲ 2.9×10 topics
- Drug Resistance2▲ 14×3 topics
- Global Health2▲ 25×2 topics
- Genomic Analysis2▲ 13×4 topics
- Antimicrobial Stewardship2▲ 70×1 topic
- Bacterial Infections2▲ 70×1 topic
- Microbial Communities2▲ 7.2×3 topics
- Virus2▲ 33×3 topics
- Genetic Diversity2▲ 6.5×5 topics
- Respiratory Infections2▲ 25×2 topics
- SARS-CoV-22▲ 8.6×5 topics
- Vaccination2▲ 40×2 topics
- Amoebae1▲ 379×1 topic
- Antifungal Therapy1▲ 30×2 topics
- Genomics1▲ 9.2×3 topics
- Immunity1▲ 6.9×4 topics
- Legionella1▲ 379×1 topic
- Community-Acquired Pneumonia1▲ 73×1 topic
- Pneumococcal Conjugate Vaccine1▲ 73×1 topic
- Biofilms1▲ 46×2 topics
- Epidemiological Study1▲ 36×2 topics
Which research topics does European Society of Clinical Microbiology and Infectious Diseases publish most on?
By volume in 2022–2025: Clostridium difficile and Clostridium perfringens research, Antibiotic Use and Resistance, Legionella and Acanthamoeba research and Pneumonia and Respiratory Infections.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Clostridium difficile and Clostridium perfringens research Infectious Diseases 2 works
- 2 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 2 works
- 3 Legionella and Acanthamoeba research Endocrinology 1 works
- 4 Pneumonia and Respiratory Infections Epidemiology 1 works
- 5 Bacterial biofilms and quorum sensing Molecular Biology 1 works
- 6 Herpesvirus Infections and Treatments Epidemiology 1 works
- 7 Bacterial Infections and Vaccines Microbiology 1 works
- 8 Bacteriophages and microbial interactions Ecology 1 works
- 9 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 1 works
- 10 Antimicrobial Resistance in Staphylococcus Infectious Diseases 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has European Society of Clinical Microbiology and Infectious Diseases's research output changed?
Output in 2018–2022 was 143% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Basel
- University of Basel
- Novartis (Switzerland)
- University Hospital of Basel
- Roche (Switzerland)
- Swiss Tropical and Public Health Institute
- Multidisciplinary Digital Publishing Institute (Switzerland)
- University Children’s Hospital Basel
- Bank for International Settlements
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.